Advertisement
Advertisement

STIM

STIM logo

Neuronetics, Inc. Common Stock

4.37
USD
-0.06
-1.47%
Apr 30, 15:16 UTC -4
Open

Neuronetics, Inc. Common Stock Profile

About

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States.

Info & Links

CEO

Keith J. Sullivan

Headquarters

3222 PHOENIXVILLE PIKE
MALVERN, PA 19355, UNITED STATES

Sector

Medical

Auditor

KPMG LLP

Share holders

56

Employees

716

Neuronetics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

287.28M

Enterprise Value

322.97M

Enterprise Value/EBITDA(ttm)

-9.94

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.00

Price to Book(mrq)

15.51

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

72.74%

Operating Margin(ttm)

-44.00%

Profit Margin(ttm)

-58.32%

Return on Equity(ttm)

-141.24%

Return on Invested Capital(ttm)

-62.72%

Return on Assets(ttm)

-32.77%

Income Statement

Revenue(ttm)

74.89M

Revenue Per Share(ttm)

1.14

Gross Profit(ttm)

54.16M

EBITDA(ttm)3

-32.49M

Net Income Available to Common(ttm)

-43.71M

Diluted EPS(ttm)

-1.23

Share Statistics

Beta (5Y Monthly)

2.17

52-Week Change

23.48%

S&P 500 52-Week Change

9.54%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

65.81M

Dividend Yield

0.00%

Float4

27.37M

% Held by Insiders

9.80%

% Held by Institutions

53.59%

Balance Sheet

Total Cash(mrq)

19.66M

Total Cash Per Share(mrq)

0.30

Total Debt(mrq)

55.15M

Total Debt/Equity(mrq)

173.44%

Current Ratio(mrq)

1.86%

Quick Ratio(mrq)

2.87%

Book Value Per Share(mrq)

0.57

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.98

Free Cash Flow(ytd)

-32.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement